CoQ10 for Male Fertility & Sperm Quality: What Human Studies Show

CoQ10 for male fertility has more human research than many supplement claims in reproductive health. Randomized trials and meta-analyses report improvements in sperm concentration, motility and other semen parameters in some men with idiopathic infertility. The harder question is whether those laboratory improvements translate into more pregnancies and live births.

Direct answer: CoQ10 can improve selected semen parameters in some infertile men, but evidence for pregnancy is less precise and a live-birth benefit has not been firmly established. It should be viewed as a possible adjunct—not a substitute for diagnosing the cause of male infertility.

What does the newest meta-analysis show?

The 2025 systematic review and meta-analysis included nine studies and 781 men with idiopathic infertility. CoQ10 improved several semen outcomes.

• Sperm concentration increased by about 10.22 million/mL in the pooled estimate.
• Semen volume increased modestly.
• Total motility increased by roughly 4.95 percentage points.
• The pooled clinical-pregnancy estimate favored CoQ10, but the confidence interval was wide.

This is useful evidence, but the pregnancy result was based on fewer events than the semen outcomes. A large odds ratio with a wide confidence interval is a signal of uncertainty, not a guarantee.

What did older meta-analysis find?

The 2013 meta-analysis pooled three randomized trials involving 296 men. CoQ10 increased seminal CoQ10 and improved sperm concentration and motility. Pregnancy was not significantly increased, and none of the included trials reported live birth.

One trial included in that older evidence base later received a formal Expression of Concern, which lowers confidence in the pooled numerical estimates. Newer reviews should therefore receive more weight than simply repeating an old positive result.

Randomized evidence: sperm motility and CoQ10 status

The Balercia randomized trial tested CoQ10 200 mg/day for six months in men with idiopathic asthenozoospermia. CoQ10 increased seminal and sperm-cell CoQ10 concentrations and improved motility and kinetic measures.

The trial did not establish improved pregnancy or live birth. It therefore supports a biological and semen-quality effect, not a complete fertility-outcome claim.

Not every randomized trial is positive

The 2011 randomized trial used 200 mg/day for 12 weeks in men with idiopathic oligoasthenoteratozoospermia. CoQ10 improved seminal antioxidant capacity and reduced oxidative-stress markers, but conventional semen parameters did not significantly improve.

This is valuable counterevidence. A mechanistic improvement in oxidative defense does not automatically translate into better sperm count, motility or morphology.

CoQ10 plus L-carnitine

A 2025 four-arm randomized trial compared CoQ10 200 mg/day, L-carnitine 1 g/day, the combination, and placebo for three months. CoQ10 monotherapy improved sperm concentration, and active groups improved motility, morphology and sperm-DNA-fragmentation measures. The combination generally produced larger changes.

That trial is useful for men considering both supplements, but the combination result cannot tell us that CoQ10 alone produced the entire combined effect. It also did not measure pregnancy or live birth.

For the combination itself, see CoQ10 and L-Carnitine.

A research-integrity warning: the 2012 ubiquinol trial

A widely cited 2012 ubiquinol male-infertility study reported large improvements in semen parameters. The journal issued a formal Expression of Concern in 2023. That means its impressive effect sizes should not be used as dependable proof.

Our Research Data Center entry preserves the paper for transparency but grades it as compromised evidence.

Does CoQ10 increase pregnancy or live birth?

Pregnancy evidence is suggestive, not secure. The 2025 CoQ10-specific meta-analysis reported a favorable pooled clinical-pregnancy estimate, but few events produced a wide confidence interval. A broader 2025 systematic review of dietary supplements in male infertility did not find convincing evidence that supplements as a class improve pregnancy or live birth.

The honest hierarchy is:

1. Semen parameters: strongest support.
2. Clinical pregnancy: possible signal, less precise.
3. Live birth: not established.

What dose has been studied for male fertility?

Many trials use approximately 200–300 mg/day, often for at least three months. That range reflects the research literature, not a proven universally optimal dose. The condition, formulation, treatment duration and other interventions differ across studies.

Three months is biologically plausible because spermatogenesis takes time, but longer use has also been studied. Dose decisions should account for the full supplement regimen and any medical conditions.

Who should get a proper male-fertility evaluation rather than relying on supplements?

CoQ10 should not delay evaluation when semen abnormalities are severe, fertility has been impaired for a prolonged period, there is testicular pain or mass, prior surgery or chemotherapy, hormonal symptoms, erectile/ejaculatory dysfunction, genetic risk, or a couple is facing time-sensitive reproductive decisions.

Male infertility may reflect varicocele, endocrine disease, obstruction, medication effects, infection, genetic causes, heat/toxin exposure or unexplained factors. A supplement cannot correct every mechanism.

What the evidence does not prove

• It does not prove that higher sperm motility guarantees conception.
• It does not establish a live-birth benefit.
• It does not show that ubiquinol is clinically superior to ubiquinone for male fertility.
• It does not validate compromised trial results under an Expression of Concern.
• It does not replace diagnosis of a correctable cause of infertility.

Final verdict

CoQ10 has credible evidence for improving selected semen parameters in men with idiopathic infertility. That makes it a reasonable adjunct to discuss. The evidence becomes less certain when moving from semen quality to pregnancy, and there is not yet strong proof of improved live birth.

The strongest way to use this evidence is to keep laboratory outcomes and reproductive outcomes separate rather than turning a motility improvement into a guaranteed fertility claim.

Continue the fertility evidence trail

• CoQ10 and Fertility
• CoQ10 for Egg Quality & IVF
• CoQ10 Dosage
• CoQ10 Safety
• CoQ10 Research Data Center

Medical note: male infertility deserves appropriate evaluation when clinically indicated. Supplements should not delay semen analysis, hormonal testing, examination or referral when the result would change treatment.